These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25131919)

  • 21. Using ACE inhibitors appropriately.
    Bicket DP
    Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perindopril: an updated review of its use in hypertension.
    Hurst M; Jarvis B
    Drugs; 2001; 61(6):867-96. PubMed ID: 11398915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perindopril: do randomised, controlled trials support an ACE inhibitor class effect? A meta-analysis of clinical trials.
    Snyman JR; Wessels F
    Cardiovasc J Afr; 2009; 20(2):127-34. PubMed ID: 19421649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of Perindopril in the reduction of cardiovascular events.
    Campbell DJ
    Vasc Health Risk Manag; 2006; 2(2):117-24. PubMed ID: 17319455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different Angiotensin-converting enzyme inhibitors and the associations with overall and cause-specific mortalities in patients with hypertension.
    Chang CH; Lin JW; Caffrey JL; Wu LC; Lai MS
    Am J Hypertens; 2015 Jun; 28(6):823-30. PubMed ID: 25498540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perindopril for the treatment of hypertension.
    Ghiadoni L
    Expert Opin Pharmacother; 2011 Jul; 12(10):1633-42. PubMed ID: 21599567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
    Bourgault C; Elstein E; Le Lorier J; Suissa S
    CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.
    Rahman M; Ford CE; Cutler JA; Davis BR; Piller LB; Whelton PK; Wright JT; Barzilay JI; Brown CD; Colon PJ; Fine LJ; Grimm RH; Gupta AK; Baimbridge C; Haywood LJ; Henriquez MA; Ilamaythi E; Oparil S; Preston R;
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):989-1002. PubMed ID: 22490878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT.
    Reisin E; Graves JW; Yamal JM; Barzilay JI; Pressel SL; Einhorn PT; Dart RA; Retta TM; Saklayen MG; Davis BR;
    J Hypertens; 2014 Jul; 32(7):1503-13; discussion 1513. PubMed ID: 24842697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for benefits of perindopril in hypertension and its complications.
    Laurent S
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preventive therapy with ACE inhibitors for coronary patients].
    Keltai M
    Orv Hetil; 2004 Feb; 145(9):461-5. PubMed ID: 15077477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G; Ferenci T; Finta E; Igaz I; Balogh S; Gasparics R; Medvegy M
    Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
    Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive medication adherence and mortality according to ethnicity: a cohort study.
    Liu Q; Quan H; Chen G; Qian H; Khan N
    Can J Cardiol; 2014 Aug; 30(8):925-31. PubMed ID: 25064583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
    Brugts JJ; de Maat MP; Boersma E; Witteman JC; van Duijn C; Uitterlinden AG; Bertrand M; Remme W; Fox K; Ferrari R; Danser AH; Simoons ML;
    Cardiovasc Drugs Ther; 2009 Apr; 23(2):171-81. PubMed ID: 19082699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.
    Marre M; Leye A
    Diab Vasc Dis Res; 2007 Sep; 4(3):163-73. PubMed ID: 17907106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.